Events > Exporting Healthcare & Life Sciences to the UAE
row-start col-md-7 #top-section top-section new-section

Exporting Healthcare & Life Sciences to the UAE

Monday, 15 March 2021 10:00 am to 11:00 am


Join key officials from the Department for International Trade (DIT) South West, British Centres for Business UAE, SAH Global and NJ Akers & Co for a comprehensive look at the UAE healthcare and life sciences market in 2021.


Register Your Place Now - Click Here


What will I learn?

This webinar is suitable for both new and existing exporters to the UAE and will cover steps to start or further expand presence in the UAE market. A comprehensive market overview, including IP considerations will be discussed, ensuring attendees receive the most relevant updates on current market conditions.


Please scroll down the page to see the list of speakers.


Who is this event for?

This webinar is open to healthcare life science businesses in the South West.

Unfortunately we are unable to accept bookings out of the South West area or bookings from service providers/intermediaries.


Register Your Place Now - Click Here


Why the UAE?

The United Arab Emirates (UAE) is one of the UK's most important trading partners and one of the fastest growing markets for UK exports. In the second quarter of 2020 UK exports to the United Arab Emirates had risen YOY by 7%, amounting to £11.7bn.

The healthcare sector in the UAE is expanding rapidly; a steadily growing population, increasing average incomes, heightening awareness of health issues and the rising prevalence of lifestyle-based diseases are all increasing demand for healthcare. Key economic priorities, including enhancing inward investment in pharmaceutical manufacturing and R&D sectors offer real opportunities for UK clinical expertise and products.

Medical tourism also represents a key sector within Dubai’s healthcare planning. Newly built medical facilities offer opportunities for UK companies to fill gaps in provision in areas such as oncology, paediatrics, mental health, primary care, trauma, emergency services and long-term rehabilitation. There’s also a need for high quality equipment, digital health solutions, high quality training for staff, facilities management and infrastructure construction.


Register Your Place Now - Click Here


Please Note: We will send you details of the online platform and login details prior to the event.


This event is organised in association with the Western Gateway Partnership.


Business West (delivery partner for the Department for International Trade)  is committed to providing a professional, friendly, safe and welcoming environment for all participants at its events. Inappropriate behaviour on video, audio & chat facilities will not be tolerated during any portion of a meeting or event. It will be at the sole discretion of the host/facilitator to immediately expel any participants from the event if their behaviour is deemed to be inappropriate and/or offensive.

Privacy Policy

We take your data very seriously and are committed to the privacy and security of it. This event is organised by Business West, delivery partner for The Department of International Trade for the SW,  their privacy policies are available at DIT Personal Information Charter.

row-end col-sm-12 col-md-5
row-start col-xs-12 colour-section row-end


Jamie Shaw, Healthcare Life Science Sector Specialist at DIT - Western Gateway

Jamie comes with significant private sector experience where most recently he was based overseas as an International Account Manager for China’s largest medical device manufacturer, Mindray. Jamie worked with overseas subsidiaries within the business and supported/implemented new direct/indirect sales channels in a number of territories; working with both public and private sector healthcare institutions.


Pippa Russo Trade and Investment Advisor – Life Sciences, British Embassy Abu Dhabi, UAE

Pippa joined the Foreign, Commonwealth and Development Office in 2003.

Pippa became Trade and Investment Advisor for Life Sciences at the British Embassy Abu Dhabi in September 2020. She is responsible for developing UK trade and investment in the life sciences sector with the UAE. Pippa leads on identifying opportunities in the market, bringing them to UK companies and supporting UK business as they navigate the UAE system.

She was previously First Secretary, Defence and Security at the British Embassy Abu Dhabi from 2016-2020. Pippa is a career diplomat and was posted to the UK Mission to the United Nations in New York 2008-2011. She has also held numerous positions within the FCDO in London ranging from bilateral political work, to consular and press/ media.

Pippa has a Masters degree in International Relations. She is married to a fellow Diplomat (also serving in Abu Dhabi) and they have 2 young daughters

Finola Hegarty Trade and Investment Advisor – Healthcare, British Embassy UAE

Finola, known as Fin has lived and worked in the UAE for over ten years. Previously working for one of the biggest educational companies in the world, GEMS Education. Her role was business development and to oversee the enrolment teams in the Abu Dhabi cluster of schools.

Fin joined the British Embassy Abu Dhabi in July 2018 where she worked in the Defence & Security team for two years and has recently joined the Healthcare team as Healthcare Advisor for the UAE. An exciting and unique time to join any team but especially the Healthcare sector, never a dull moment.Home is the South of Spain where she lived and worked for twenty years.  She has a degree in Marketing and Business Studies.The UAE is a market and culture she knows very well and is here to support in any way she can.

Feroz Agad, Founder, Chairman and CEO,  SAH GLOBAL

SAH is led by Mr. Feroz Agad, an accomplished executive, investor and entrepreneur with over 25 years’ experience of managing multimillion-dollar corporations in industries including healthcare, information technology, real estate, communications, and tourism. By capitalizing on his business acumen, technical expertise, interpersonal skills and strategic mindset, Mr. Agad has been instrumental in penetrating new markets and achieving significant sales growth for the companies he has founded and managed.

Mr. Agad has pioneered the development of many cutting-edge forward-looking technologies such as the establishment of internet kiosks (1999), the establishment of ADLSAT (2000) a satellite based broadband service provider in remote locations even before fiber broadband access was available to many parts of the world. Through ADLSAT the company partnered to bring Healthcare Kiosk hubs to remote areas in Africa and various parts of the Asian Sub- Continent which included India and Pakistan.

In 2004, Mr. Agad established SAH Global with the vision of using the company as a catalyst to bring cutting edge healthcare technology to the developing world. Today, SAH Global operations span across 4 continents in over 10 counties in various sectors of Healthcare (from medical treatment abroad to establishing a network of diagnostic imaging and oncology treatment centers) and Real Estate. Through the SAH Care division, his company provides cutting edge medical treatment to patients from around the world, that travel to SAH’s network of cancer centers in the USA.

In his overall reach in the fight against cancer, Mr. Agad has particularly impacted the Industry of radiation oncology (which includes proton therapy & boron neutron capture therapy), radiopharmaceutical production (nuclear medicine), and molecular diagnostic imaging. He has demonstrated an exceptional spirit of innovation to ensure patients from across the world have access to best treatment available. Mr. Agad defines the future readiness of the Oncology organizations to not only meet the market demand, but to provide compassionate and comprehensive care to patients wherever they live.

In November 2018, Mr. Feroz Agad was awarded with a Top 50 Smart Healthcare Leaders Award by the Smart Health Conference, and SAH was awarded and recognized as one of the “Top 50 Healthcare Companies” in the world for its contribution to the healthcare sector.


Graeme McCallum, Patent & Trade Mark Attorney at NJ Akers & Co

Graeme McCallum is a qualified UK and European patent attorney and trade mark attorney and an IP Litigator. He has over 20 years experience helping clients to protect and enforce their intellectual property rights.

Graeme has a broad range of experience in different medical related technologies, including surgical instruments, stents and grafts, catheters, NMR imaging, drug delivery systems and anti-bacterial compositions as well as more general healthcare technologies such as monitors, beds and mattresses.

Graeme has substantial experience of assisting start-ups and SMEs, as well as managing the IP portfolios of multi-national corporations. He assists clients to extract maximum value from their innovations and to ensure that their IP strategies are aligned with their business strategies and work to support the business. He has particular expertise in advising clients on brand protection and on high value and standards related patent cases.